Chlamydia Infection Diagnostics and Therapeutics Market: By diagnostics (Direct Fluorescent Tests, Nucleic Acid Amplification Tests, Others), By Therapeutics ( Antibiotics (Tetracyclines, Macrolides, Quinolones) Others), By End-user (Hospitals and Hospital Pharmacies, Retail Pharmacies, Others) Geography.  

Purchase Option

$ 4400
$ 6600
$ 8900

Chlamydia Infection Diagnostics And Therapeutics Market size was valued at USD 2.6 billion in 2022 and is poised to grow at a CAGR of 6.1% from 2023-2029. Chlamydia is a sexually transmitted disease (STD) caused by the bacteria Chlamydia trachomatis, and it can be transmitted to a baby at birth. chlamydia infection diagnostics and therapeutics market usually does have any symptoms but often infected may have symptoms such as genital pain and genital discharge both in men and women. Furthermore, chlamydia infection can cause health complications such as preventing women from getting pregnant or even endangering their pregnancies. Some people may experience pain in the lower abdomen, pelvis, testicle, or vagina and may also have eye discharge or spotting. Treatment may include antibiotics and anti-inflammatory agents, and a hospital stay may be required. The global chlamydia infection diagnostics and therapeutics market is growing at significant rates owing to the prevalence rate of sexually transmitted diseases. According to the World Health Organization (WHO), worldwide, more than one million sexually transmitted infections are acquired every day. Each year, an estimated of 131 million new cases of chlamydia infection are reported. Companies are focusing on the development of new ways to detect chlamydia infection in the initial stages. For instance, in December 2016,  F. Hoffmann-La Roche AG launched Cobas 6800/8800 systems for the detection of Chlamydia trachomatis and Neisseria Gonorrhoea (NG) DNA.

Chlamydia Infection Diagnostics And Therapeutics Market Key Developments:
  • In October 2016, Becton Dickinson and Company (BD) received U.S. FDA approval for BD Max Vaginal Panel, for the detection of the most common causes of vaginal infections including chlamydia trichomoniasis.

Chlamydia Infection Diagnostics And Therapeutics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.1%

Largest Market

North America

Fastest Growing Market

North-America
Chlamydia Infection Diagnostics And Therapeutics Market Dynamics

Global chlamydia infection diagnostics and therapeutics market is mainly driven by an increase in prevalence of sexually transmitted diseases worldwide. Furthermore, emergence of rapid test and advances in biotechnology are expected to boost the chlamydia infection diagnostics and therapeutics market. In addition, increase in R&D activities towards development of therapeutics for antibiotic-resistant bacteria and initiatives by government and non-government agencies (such as World Health Organization (WHO) to increase awareness about STD and their symptoms are expected to bolster the chlamydia diagnostics and therapeutics market during the forecast period. However, high cost of development, stringent regulatory procedures for the approval and bacterial drug resistance is expected to hamper the chlamydia infection diagnostics and therapeutics market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Chlamydia Infection Diagnostics And Therapeutics Market Segmentation

By Diagnostics
  • Direct Fluorescent Tests
  • Nucleic Acid Amplification Tests
  • Others
By Therapeutics
  • Antibiotics
    • Tetracyclines
    • Macrolides
    • Quinolones
    • Others
  • Others
By End-user
  • Hospitals and Hospital Pharmacies
  • Retail Pharmacies
  • Others

Frequently Asked Questions

The chlamydia infection diagnostics and therapeutics market is projected to expand at a CAGR of 6.1% during the forecast period  

Abbott Laboratories, Bio-Rad Laboratories Inc, Becton Dickinson and Company, bioMérieux, DiaSorin SpA

North America is the fastest-growing region for chlamydia infection diagnostics and therapeutics market

    1. Executive Summary
    2. Global Chlamydia Infection Diagnostics and Therapeutics Market Introduction
      • Global Chlamydia Infection Diagnostics and Therapeutics Market – Taxonomy
      • Global Chlamydia Infection Diagnostics and Therapeutics Market –Definitions
        • Diagnostics
        • Therapeutics
        • End User
    1. Global Chlamydia Infection Diagnostics and Therapeutics Market Dynamics
      • Drivers
      • Restraints
      • Opportunities/Unmet Needs of the Market
      • Trends
      • Global Chlamydia Infection Diagnostics and Therapeutics Market Dynamic Factors - Impact Analysis
      • Global Chlamydia Infection Diagnostics and Therapeutics Market – Competition Landscape
      • Epidemiology
    2. Global Chlamydia Infection Diagnostics and Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%)
      • Market OpportunityAnalysis
    3. Global Chlamydia Infection Diagnostics and Therapeutics Market, By Diagnostics, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Direct Fluorescent Tests
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Nucleic Acid Amplification Tests
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Others
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
    1. Global Chlamydia Infection Diagnostics and Therapeutics Market Forecast, By Therapeutics,2018 - 2022 and Forecast, 2023 - 2029
      • Antibiotics
        • Tetracyclines
          • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Macrolides
          • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Quinolones
          • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Others
          • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
          • Others
    1. Global Chlamydia Infection Diagnostics and Therapeutics Market Forecast, By End User, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Hospitals and Hospital Pharmacies
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Retail Pharmacies
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Others
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
    1. Global Chlamydia Infection Diagnostics and Therapeutics Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • North America
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Europe
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Asia-Pacific
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Latin America
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Middle East and Africa
        • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Global Chlamydia Infection Diagnostics and Therapeutics Market - Opportunity Analysis Index, By Diagnostics, By Therapeutics, By End User, and Region, 2023 - 2029
    2. North America Chlamydia Infection Diagnostics and Therapeutics MarketAnalysis,2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Diagnostics Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
        • Direct Fluorescent Tests
        • Nucleic Acid Amplification Tests
        • Others
      • Therapeutics Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Antibiotics
          • Tetracyclines
          • Macrolides
          • Quinolones
          • Others
        • Others
      • End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospitals and Hospital Pharmacies
        • Retail Pharmacies
        • Others
      • Country Analysis 2019 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • U.S.
        • Canada
      • North America Chlamydia Infection Diagnostics and Therapeutics Market - Opportunity Analysis Index, By Diagnostics, By Therapeutics, By End User, and Country, 2023 - 2029
      • North America Chlamydia Infection Diagnostics and Therapeutics Market Dynamics – Trends
    3. Europe Chlamydia Infection Diagnostics and Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Diagnostics Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
        • Direct Fluorescent Tests
        • Nucleic Acid Amplification Tests
        • Others
      • Therapeutics Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Antibiotics
          • Tetracyclines
          • Macrolides
          • Quinolones
          • Others
        • Others
      • End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospitals and Hospital Pharmacies
        • Retail Pharmacies
        • Others
      • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Germany
        • UK
        • France
        • Spain
        • Italy
        • Russia
        • Poland
        • Rest of Europe
      • Europe Chlamydia Infection Diagnostics and Therapeutics Market - Opportunity Analysis Index, By Diagnostics, By Therapeutics, By End User, and Country, 2023 - 2029
      • Europe Chlamydia Infection Diagnostics and Therapeutics Market Dynamics – Trends
    4. Asia-Pacific Chlamydia Infection Diagnostics and Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Diagnostics Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
        • Direct Fluorescent Tests
        • Nucleic Acid Amplification Tests
        • Others
      • Therapeutics Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Antibiotics
          • Tetracyclines
          • Macrolides
          • Quinolones
          • Others
        • Others
      • End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospitals and Hospital Pharmacies
        • Retail Pharmacies
        • Others
      • Country Analysis2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Japan
        • China
        • India
        • ASEAN
        • Australia & New Zealand
        • Rest of Asia-Pacific
      • Asia-Pacific Chlamydia Infection Diagnostics and Therapeutics Market - Opportunity Analysis Index, By Diagnostics, By Therapeutics, By End User, and Country, 2023 - 2029
      • Asia-Pacific Chlamydia Infection Diagnostics and Therapeutics Market Dynamics – Trends
    5. Latin America Chlamydia Infection Diagnostics and Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Diagnostics Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
        • Direct Fluorescent Tests
        • Nucleic Acid Amplification Tests
        • Others
      • Therapeutics Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Antibiotics
          • Tetracyclines
          • Macrolides
          • Quinolones
          • Others
        • Others
      • End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospitals and Hospital Pharmacies
        • Retail Pharmacies
        • Others
      • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Brazil
        • Mexico
        • Argentina
        • Venezuela
        • Rest of Latin America
      • Latin America Chlamydia Infection Diagnostics and Therapeutics Market - Opportunity Analysis Index, By Diagnostics, By Therapeutics, By End User, and Country, 2023 - 2029
      • Latin America Chlamydia Infection Diagnostics and Therapeutics Market Dynamics – Trends
    6. Middle East and Africa Chlamydia Infection Diagnostics and Therapeutics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Diagnostics Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
        • Direct Fluorescent Tests
        • Nucleic Acid Amplification Tests
        • Others
      • Therapeutics Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Antibiotics
          • Tetracyclines
          • Macrolides
          • Quinolones
          • Others
        • Others
      • End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospitals and Hospital Pharmacies
        • Retail Pharmacies
        • Others
      • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Gulf Cooperation Council (GCC) Countries
        • Israel
        • South Africa
        • Rest of MEA
      • MEA Chlamydia Infection Diagnostics and Therapeutics Market - Opportunity Analysis Index, By Diagnostics, By Therapeutics, By End User, and Country, 2023 - 2029
      • MEA Chlamydia Infection Diagnostics and Therapeutics Market Dynamics – Trends
    7. Competition Landscape
      • Strategic Dashboard of Top Market Players
      • Company Profiles (Introduction, Financial Analysis, Diagnostics& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
        • Novartis AG (Switzerland)
        • Bio-Rad Laboratories Inc. (U.S.)
        • Hoffmann-La Roche AG (Switzerland)
        • The Danaher Corporation (U.S.)
        • Abbott Laboratories (U.S.)
        • bioMérieux (France)
        • Siemens AG (Germany)
        • DiaSorin SpA (Italy)
        • Becton Dickinson and Company (U.S.)
        • Thermo Fisher Scientific (U.S.)
    1. Research Methodology
    2. Key Assumptions and Acronym
  • Novartis AG (Switzerland)
  • Bio-Rad Laboratories Inc. (U.S.)
  • F. Hoffmann-La Roche AG (Switzerland)
  • The Danaher Corporation (U.S.)
  • Abbott Laboratories (U.S.)
  • BioMérieux (France)
  • Siemens AG (Germany)
  • DiaSorin SpA (Italy)
  • Becton Dickinson and Company (U.S.)
  • Thermo Fisher Scientific (U.S.)

Adjacent Markets